PolyPid Ltd.

US$6.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PYPDHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (50.56%)
Div yield —
ROE (243.59%)
Biotechnology
Beta (5Y) 1.44
PE TTM —
TSR TTM 60.31%
Mkt cap US$124.7M
ROIC (109.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.36
3.59%
(59.25%)
Hold 8|1|5|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.11
0.12
0.14
36.98%
35.43%
38.23%
45.08%
Revenue$M
7.548
7.460
7.278
7.403
9.28%
1.97%
1.94%
1.94%
Peers (US$124.7M)
Cap (US$)
PE
203.6M
—
185.7M
5.250x
124.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.803
0.193
0.148
EBIT/Intx
3.083
0.446
0.368
Own earn%
(4.65)
(106.04)
(92.68)
Sh yield%
50.44
31.90
31.84
Owners
Insiders/Inst%
11.70
26.17
Short interest%
5.97
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
3